Medicare Enrolled
Dr. Narendra Narepalem, M.D.
Urology Physician · Mount Prospect, IL
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Narepalem from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Narepalem?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Narepalem
Dr. Narendra Narepalem is an urology physician in Mount Prospect, IL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Narepalem performed 2,452 Medicare services across 1,703 unique beneficiaries.
Between the years covered by Open Payments, Dr. Narepalem received a total of $7,195 from 58 pharmaceutical and/or device companies across 309 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Narepalem is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 37% volume in IL
$7,195 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,452
Medicare services
Top 37% in IL for urology physician
1,703
Unique beneficiaries
$74
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~123 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
586 | $95 | $228 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
364 | $69 | $163 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
213 | $8 | $20 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
205 | $43 | $129 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
197 | $2 | $20 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 162 | $135 | $2,000 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
159 | $8 | $100 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
114 | $198 | $930 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
77 | $127 | $302 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
60 | $144 | $324 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
42 | $67 | $140 |
| Limited retroperitoneal ultrasound A focused ultrasound exam of the area behind the abdominal cavity to evaluate specific structures. |
33 | $46 | $490 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
33 | $29 | $160 |
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
32 | $40 | $154 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
29 | $111 | $260 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
26 | $111 | $590 |
| Initial hospital admission, low complexity Initial hospital inpatient or observation care for a new patient involving straightforward or low-level medical decision making, with at least 40 minutes total time on the date of the encounter. |
21 | $71 | $190 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
20 | $38 | $103 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
15 | $107 | $2,140 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
14 | $194 | $1,010 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
14 | $43 | $80 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
13 | $101 | $200 |
| Endoscopic removal of foreign body, stone, or stent from urethra or bladder A procedure to remove a foreign object, stone, or stent from the urethra or bladder using an endoscope. The endoscope is a thin tube with a camera inserted into the urinary tract to locate and extract the item. |
12 | $274 | $1,130 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
11 | $59 | $204 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.1% high complexity
10.8% medium
88.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$7,195
Total received (2018-2024)
Avg $1,028/year across 7 years
Top 24% in IL for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
58
Companies
309
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,195 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$917
2023
$1,223
2022
$1,182
2021
$1,108
2020
$395
2019
$1,513
2018
$855
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Blue Earth Diagnostics Limited
$142
ABBVIE INC.
$131
Tolmar, Inc.
$88
Teleflex LLC
$64
Antares Pharma, Inc.
$58
Merck Sharp & Dohme LLC
$55
PFIZER INC.
$51
Janssen Biotech, Inc.
$47
Smith+Nephew, Inc.
$33
Astellas Pharma US Inc
$32
Novartis Pharmaceuticals Corporation
$31
COLOPLAST CORP
$24
Olympus America Inc.
$24
Laborie Medical Technologies Corp.
$23
PROGENICS PHARMACEUTICALS, INC.
$22
Calyxo, Inc.
$21
PROCEPT BioRobotics Corporation
$19
Endo USA, Inc.
$18
Verity Pharmaceuticals Inc.
$17
Endo Pharmaceuticals Inc.
$16
Top 3 companies account for 39.3% of 2024 payments
All-time payments by company (2018-2024) ›
Intuitive Surgical, Inc.
$941
PFIZER INC.
$535
Astellas Pharma US Inc
$505
Antares Pharma, Inc.
$394
Coloplast Corp
$372
Dendreon Pharmaceuticals LLC
$323
Blue Earth Diagnostics Limited
$307
ABBVIE INC.
$302
Janssen Biotech, Inc.
$297
Olympus America Inc.
$252
Myovant Sciences Inc.
$214
Tolmar, Inc.
$185
NeoTract Inc.
$156
AstraZeneca Pharmaceuticals LP
$148
PROCEPT BioRobotics Corporation
$140
Endo Pharmaceuticals Inc.
$140
Merck Sharp & Dohme LLC
$125
AbbVie Inc.
$111
Teleflex LLC
$110
Accord Healthcare, Inc.
$104
Travere Therapeutics, Inc.
$92
Bard Access Systems, Inc.
$90
Supernus Pharmaceuticals, Inc.
$87
TOLMAR Pharmaceuticals, Inc.
$83
Bayer HealthCare Pharmaceuticals Inc.
$73
BOSTON SCIENTIFIC CORPORATION
$73
Sumitomo Pharma America, Inc.
$71
Novartis Pharmaceuticals Corporation
$66
Clarus Therapeutics Inc.
$61
Rochester Medical Corporation
$56
Boston Scientific Corporation
$55
Merck Sharp & Dohme Corporation
$54
ROCHESTER MEDICAL CORPORATION
$52
AbbVie, Inc.
$50
Ambu Inc.
$45
Verity Pharmaceuticals Inc.
$37
Axonics, Inc.
$34
Smith+Nephew, Inc.
$33
Allergan Inc.
$33
Osiris Therapeutics Inc.
$30
ConvaTec Inc.
$30
AngioDynamics, Inc.
$25
Prometheus Laboratories Inc.
$25
COLOPLAST CORP
$24
UROVANT SCIENCES INC
$24
Laborie Medical Technologies Corp.
$23
PROGENICS PHARMACEUTICALS, INC.
$22
Amgen Inc.
$21
Calyxo, Inc.
$21
Abbott Laboratories
$20
Retrophin, Inc.
$18
Endo USA, Inc.
$18
Aesculap, Inc.
$17
UroGen Pharma, Inc.
$17
Mission Pharmacal Company
$15
Alnylam Pharmaceuticals Inc.
$15
Avadel Specialty Pharmaceuticals, LLC
$12
EDAP TECHNOMED INC
$12
Top 3 companies account for 27.5% of all-time payments
Associated products mentioned in payments ›
(815) Thiola · AQUABEAM ROBOTIC SYSTEM · AQUABEAM SYSTEM · AVEED · Androgel · Axium Sheath Braided DRG · Axonics · Axumin · BOTOX · BOTOX THERAPEUTIC · CAMCEVI · CVAC ASPIRATION SYSTEM · Coloplast TFL Drive · Da Vinci Surgical System · ELIGARD · ERLEADA · Erleada · GEMTESA · GENERAL ERECTILE DYSFUNCTION · GENTLECATH · GRAFIX · GRAFIX/GRAFIXPL/STRAVIX · GREENLIGHT · Goby · JATENZO · KEYTRUDA · LITHOVUE · LUPRON DEPOT · LYNPARZA · Lupron · Lupron Depot · MYRBETRIQ · Myrbetriq · NO APPLICABLE MARKETED PRODUCT NAME · NOCDURNA · NanoKnife · Noctiva · Nubeqa · ORGOVYX · OXLUMO · Olympus Laser Devices · PERISTEEN · PLUVICTO · POSLUMA · PROGEL · PROVENGE · PYLARIFY · Porges Coloplast · Proleukin · Prolia · Rezum Generator · SPEEDICATH · STRAVIX PL · SUTENT · TOVIAZ · Thiola · Trelstar · UROLIFT · Uribel · UroLift · XIAFLEX · XTANDI · XYOSTED · Xtandi · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Urology physicians within 10 mi
315
Per 100K population
6.1
County median income
$81,797
Nearest hospital
CHICAGO BEHAVIORAL HOSPITAL
2.4 mi
2.4 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Narepalem is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Narepalem experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Narepalem performed 586 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Narepalem receive payments from pharmaceutical companies?
Yes. Dr. Narepalem received a total of $7,195 from 58 companies across 309 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Narepalem's costs compare to other urology physicians in Mount Prospect?
Dr. Narepalem's average Medicare payment per service is $74. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Narepalem) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Mount Prospect
Browse urology physicians in Mount Prospect ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in IL
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in IL
Which IL urology physicians receive the most from drug and device companies.
By company
Intuitive Surgical, Inc. Payments to Doctors
See all physicians who received payments from Intuitive Surgical, Inc.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology